CUORiPS Inc. announced that it has entered into an agreement for private placements of shares for gross proceeds of ¥1.6 billion in a round of funding on March 15, 2021. The transaction included participation from JAFCO SV6 Series a fund managed by JAFCO Group Co., Ltd. (TSE : 8595), JIC Venture Growth Investments Co., Ltd., Osaka University Venture Capital Co., Ltd., Fujifilm Corporation, CellSource Co., Ltd. (TSE : 4880), Kyoto-University-Venture NVCC No.2 Investment Limited Partnership and other investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,275 JPY | +1.03% | -4.14% | -0.31% |
2023 | Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 23-DEC-2023. | CI |
2023 | MEDERI Inc. announced that it has received funding from CellSource Co., Ltd. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.31% | 161M | |
-24.16% | 7.76B | |
+68.65% | 4.33B | |
+2.72% | 2.63B | |
-2.98% | 2.64B | |
-46.17% | 2.16B | |
-15.27% | 1.75B | |
-22.12% | 1.46B | |
+13.62% | 1.17B | |
-43.81% | 1.14B |
- Stock Market
- Equities
- 4880 Stock
- News CellSource Co., Ltd.
- Cuorips Inc. announced that it has received ¥1.6 billion in funding from JIC Venture Growth Investments Co., Ltd., JAFCO Group Co., Ltd., Osaka University Venture Capital Co., Ltd., Fujifilm Corporation, CellSource Co., Ltd., Kyoto-University-Venture NVCC No.2 Investment Limited Partnership